Alpha Cognition Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ACOG Nasdaq 2836 www.alphacognition.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alpha Cognition Inc.

Alpha Cognition Strengthens Its Board of Directors with Appointment of Bethany Sensenig - Apr 20th, 2026 3:00 pm
Alpha Cognition Inc.'s (NASDAQ:ACOG) Path To Profitability - Apr 19th, 2026 6:45 am
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Apr 15th, 2026 6:00 pm
Alpha Cognition Inc. (ACOG) Soars 8.6%: Is Further Upside Left in the Stock? - Apr 2nd, 2026 7:03 am
Alpha Cognition Receives Issued U.S. Patent for ALPHA-1062 for Treatment of Traumatic Brain Injury - Apr 1st, 2026 2:30 pm
Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q425 - Apr 1st, 2026 7:51 am
Alpha Cognition (ACOG) Q4 2025 Earnings Transcript - Apr 1st, 2026 6:59 am
Alpha Cognition Inc. Common Stock Q4 2025 Earnings Call Summary - Mar 27th, 2026 6:30 am
Alpha Cognition Q4 Earnings Call Highlights - Mar 26th, 2026 3:48 pm
Alpha Cognition Inc. (ACOG) Reports Q4 Loss, Lags Revenue Estimates - Mar 26th, 2026 3:10 pm
Alpha Cognition Inc. Reports Fiscal 2025 Financial Results and Provides Operational Update - Mar 26th, 2026 2:01 pm
Water Giant With $7 Billion in Revenue Draws $7.5 Million Investment, and Shares Are Surging This Year - Mar 15th, 2026 5:53 pm
Payments Stock Down 30% Draws $6 Million Bet as Company Posts $4 Billion in Revenue - Mar 15th, 2026 5:46 pm
Alpha Cognition (Nasdaq: ACOG) to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on Thursday, March 26, 2026 - Mar 13th, 2026 11:46 am
Alpha Cognition to Present New Clinical on ZUNVEYL® (Benzgalantamine) at Multiple Upcoming Alzheimer’s Association International Conferences - Mar 10th, 2026 6:30 am
Solas Capital Loads Up On Kyndryl With 407,000 Shares Bought - Mar 5th, 2026 4:10 pm
Alpha Cognition Announces First Patient Enrolled in BEACON Real-World Effectiveness Study - Feb 25th, 2026 6:30 am
Alpha Cognition Announces Issuance of Additional U.S. Patent Covering ZUNVEYL ® Dosing Regimens - Feb 18th, 2026 6:30 am
Several Insiders Invested In Alpha Cognition Flagging Positive News - Feb 16th, 2026 3:47 am
Alpha Cognition Provides 2026 Corporate Update Highlighting Strategic Priorities and 2025 Commercial Execution - Jan 7th, 2026 2:30 pm